Ifp Advisors, Inc Replimune Group, Inc. Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 4 shares of REPL stock, worth $51. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$51% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding REPL
# of Institutions
152Shares Held
68.3MCall Options Held
52.3KPut Options Held
80.3K-
Baker Bros. Advisors LP New York, NY11MShares$142 Million1.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.88MShares$127 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$62.5 Million9.16% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$61.4 Million3.43% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$60.6 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $634M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...